Theranostics 2012; 2(12):1117-1126. doi:10.7150/thno.4381


Lipid- and Polymer-Based Nanostructures for Cancer Theranostics

Brian T. Luk, Ronnie H. Fang, Liangfang Zhang

Department of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See for full terms and conditions.
Luk BT, Fang RH, Zhang L. Lipid- and Polymer-Based Nanostructures for Cancer Theranostics. Theranostics 2012; 2(12):1117-1126. doi:10.7150/thno.4381. Available from

File import instruction


The relatively new field of nanotheranostics combines the advantages of in vivo diagnosis with the ability to administer treatment through a single nano-sized carrier, offering new opportunities for cancer diagnosis and therapy. Nanotheranostics has facilitated the development of nanomedicine through direct visualization of drug blood circulation and biodistribution. From a clinical perspective, nanotheranostics allows therapies to be administered and monitored in real time, thus decreasing the potential of under- or over-dosing and allowing for more personalized treatment regimens. Herein, we review recent development of nanotheranostics using lipid- and polymer-based formulations, with a particular focus on their applications in cancer research. Recent advances in nanotechnology aimed to combine therapeutic molecules with imaging agents for magnetic resonance imaging, radionuclide imaging, or fluorescence imaging are discussed.

Keywords: nanotheranostics, liposomes, polymeric nanoparticles, magnetic resonance imaging, radionuclide imaging, fluorescence imaging